Clover Health Investments (NASDAQ:CLOV) Shares Down 4.5% - What's Next?

Market Beat
2025.02.01 14:34
portai
I'm PortAI, I can summarize articles.

Clover Health Investments (NASDAQ:CLOV) shares fell 4.5% to $4.39, with trading volume down 84% from average levels. Analysts have mixed views, with UBS rating it "neutral" at a $4.00 target, while Craig Hallum rates it "buy" at $6.00. The company reported a quarterly EPS of ($0.02), beating estimates, but revenue of $330.99 million fell short of expectations. Institutional investors have increased their stakes, with 19.77% of shares held by hedge funds. Analysts expect a yearly EPS of -0.12 for Clover Health.

Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report)'s stock price was down 4.5% on Wednesday . The company traded as low as $4.43 and last traded at $4.39. Approximately 1,149,289 shares traded hands during trading, a decline of 84% from the average daily volume of 6,965,554 shares. The stock had previously closed at $4.59.

Analyst Ratings Changes

Several research firms recently weighed in on CLOV. UBS Group began coverage on shares of Clover Health Investments in a research note on Monday, October 7th. They set a "neutral" rating and a $4.00 target price for the company. Craig Hallum initiated coverage on Clover Health Investments in a report on Tuesday, December 17th. They issued a "buy" rating and a $6.00 target price on the stock.

View Our Latest Research Report on Clover Health Investments

Clover Health Investments Price Performance

The firm has a market capitalization of $2.23 billion, a PE ratio of -22.30 and a beta of 1.95. The business has a 50-day simple moving average of $3.58 and a 200-day simple moving average of $3.19.

Clover Health Investments (NASDAQ:CLOV - Get Free Report) last issued its quarterly earnings results on Wednesday, November 6th. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.03) by $0.01. Clover Health Investments had a negative return on equity of 25.46% and a negative net margin of 5.92%. The company had revenue of $330.99 million during the quarter, compared to the consensus estimate of $347.60 million. During the same period last year, the company earned ($0.09) earnings per share. On average, research analysts expect that Clover Health Investments, Corp. will post -0.12 earnings per share for the current year.

Institutional Investors Weigh In On Clover Health Investments

Several hedge funds and other institutional investors have recently modified their holdings of the business. Palacios Wealth Management LLC bought a new position in Clover Health Investments in the 4th quarter valued at $131,000. Ballentine Partners LLC bought a new position in shares of Clover Health Investments in the fourth quarter worth about $131,000. SignalPoint Asset Management LLC increased its stake in Clover Health Investments by 6.2% in the 4th quarter. SignalPoint Asset Management LLC now owns 160,074 shares of the company's stock worth $504,000 after buying an additional 9,390 shares during the period. Steph & Co. lifted its holdings in Clover Health Investments by 33.3% during the 4th quarter. Steph & Co. now owns 20,000 shares of the company's stock valued at $63,000 after buying an additional 5,000 shares in the last quarter. Finally, Graypoint LLC purchased a new stake in Clover Health Investments in the 4th quarter valued at about $632,000. 19.77% of the stock is currently owned by hedge funds and other institutional investors.

About Clover Health Investments

(Get Free Report)

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.

Featured Stories

  • Five stocks we like better than Clover Health Investments
  • What Are Dividends? Buy the Best Dividend Stocks
  • 3 Turnaround Stocks in the Early Innings With More Upside to Come
  • Where Do I Find 52-Week Highs and Lows?
  • Whirlpool: Buy This High-Yielding Value Before It Spins Higher
  • Quiet Period Expirations Explained
  • Commvault Systems: Share Price Primed to Vault Higher in 2025

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clover Health Investments Right Now?

Before you consider Clover Health Investments, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.

While Clover Health Investments currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Source: Market Beat The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.